| Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent A Radbruch, LD Weberling, PJ Kieslich, O Eidel, S Burth, P Kickingereder, ... Radiology 275 (3), 783-791, 2015 | 647 | 2015 |
| Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO) R Soffietti, U Abacioglu, B Baumert, SE Combs, S Kinhult, JM Kros, ... Neuro-oncology 19 (2), 162-174, 2017 | 516 | 2017 |
| Radiomic profiling of glioblastoma: identifying an imaging predictor of patient survival with improved performance over established clinical and radiologic risk models P Kickingereder, S Burth, A Wick, M Götz, O Eidel, HP Schlemmer, ... Radiology 280 (3), 880-889, 2016 | 416 | 2016 |
| Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study P Kickingereder, F Isensee, I Tursunova, J Petersen, U Neuberger, ... The Lancet Oncology 20 (5), 728-740, 2019 | 402 | 2019 |
| IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human … P Kickingereder, F Sahm, A Radbruch, W Wick, S Heiland, A Deimling, ... Scientific reports 5 (1), 16238, 2015 | 340 | 2015 |
| Radiogenomics of glioblastoma: machine learning–based classification of molecular characteristics by using multiparametric and multiregional MR imaging features P Kickingereder, D Bonekamp, M Nowosielski, A Kratz, M Sill, S Burth, ... Radiology 281 (3), 907-918, 2016 | 296 | 2016 |
| Large-scale radiomic profiling of recurrent glioblastoma identifies an imaging predictor for stratifying anti-angiogenic treatment response P Kickingereder, M Götz, J Muschelli, A Wick, U Neuberger, RT Shinohara, ... Clinical Cancer Research 22 (23), 5765-5771, 2016 | 268 | 2016 |
| Correction of B1‐inhomogeneities for relaxation‐compensated CEST imaging at 7 T J Windschuh, M Zaiss, JE Meissner, D Paech, A Radbruch, ME Ladd, ... NMR in biomedicine 28 (5), 529-537, 2015 | 267 | 2015 |
| Relaxation-compensated CEST-MRI of the human brain at 7 T: unbiased insight into NOE and amide signal changes in human glioblastoma M Zaiss, J Windschuh, D Paech, JE Meissner, S Burth, B Schmitt, ... Neuroimage 112, 180-188, 2015 | 248 | 2015 |
| Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma B Wiestler, D Capper, M Sill, DTW Jones, V Hovestadt, D Sturm, ... Acta neuropathologica 128, 561-571, 2014 | 240 | 2014 |
| Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma P Kickingereder, U Neuberger, D Bonekamp, PL Piechotta, M Götz, ... Neuro-oncology 20 (6), 848-857, 2018 | 222 | 2018 |
| High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent gadobutrol A Radbruch, LD Weberling, PJ Kieslich, J Hepp, P Kickingereder, W Wick, ... Investigative radiology 50 (12), 805-810, 2015 | 214 | 2015 |
| Increased signal intensity in the dentate nucleus on unenhanced T1-weighted images after gadobenate dimeglumine administration LD Weberling, PJ Kieslich, P Kickingereder, W Wick, M Bendszus, ... Investigative radiology 50 (11), 743-748, 2015 | 200 | 2015 |
| Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma A Deistung, F Schweser, B Wiestler, M Abello, M Roethke, F Sahm, ... PloS one 8 (3), e57924, 2013 | 192 | 2013 |
| Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging P Kickingereder, B Wiestler, F Sahm, S Heiland, M Roethke, ... Radiology 272 (3), 843-850, 2014 | 170 | 2014 |
| Feasibility, safety, and outcome of endovascular recanalization in childhood stroke: the Save ChildS Study PB Sporns, R Sträter, J Minnerup, H Wiendl, U Hanning, R Chapot, ... JAMA neurology 77 (1), 25-34, 2020 | 157 | 2020 |
| Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T D Paech, J Windschuh, J Oberhollenzer, C Dreher, F Sahm, JE Meissner, ... Neuro-oncology 20 (12), 1661-1671, 2018 | 152 | 2018 |
| Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology O Eidel, S Burth, JO Neumann, PJ Kieslich, F Sahm, C Jungk, ... PloS one 12 (1), e0169292, 2017 | 150 | 2017 |
| Downfield‐NOE‐suppressed amide‐CEST‐MRI at 7 Tesla provides a unique contrast in human glioblastoma M Zaiss, J Windschuh, S Goerke, D Paech, JE Meissner, S Burth, ... Magnetic resonance in medicine 77 (1), 196-208, 2017 | 149 | 2017 |
| Can virtual contrast enhancement in brain MRI replace gadolinium?: a feasibility study J Kleesiek, JN Morshuis, F Isensee, K Deike-Hofmann, D Paech, ... Investigative radiology 54 (10), 653-660, 2019 | 146 | 2019 |
Wolfgang WickUniversity of HeidelbergEmail verificata su med.uni-heidelberg.de